| scholarly article | Q13442814 |
| P2093 | author name string | Artur-Aron Weber | |
| Karsten Schrör | |||
| Jens W Fischer | |||
| Mario Sarbia | |||
| Jutta Meyer-Kirchrath | |||
| Ellen Bretschneider | |||
| Robert Pape | |||
| Kerstin Rabausch | |||
| Petra Censarek | |||
| P433 | issue | 1 | |
| P304 | page(s) | e1-6 | |
| P577 | publication date | 2004-12-09 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins | |
| P478 | volume | 96 |
| Q35906890 | Analgesic Efficacy of Firocoxib, a Selective Inhibitor of Cyclooxygenase 2, in a Mouse Model of Incisional Pain. |
| Q38161572 | Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity |
| Q34245387 | Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities |
| Q36167666 | Cardiovascular risk of selective cyclooxygenase-2 inhibitors |
| Q28298198 | Cardiovascular risk, hypertension, and NSAIDs |
| Q37049698 | Cardiovascular risk, hypertension, and NSAIDs. |
| Q55405814 | Comparison of Pulmonary and Systemic NO- and PGI2-Dependent Endothelial Function in Diabetic Mice. |
| Q44374395 | Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection Constitutive COX-2 expression and cardioprotection. |
| Q35921866 | Disruption of the 5-lipoxygenase pathway attenuates atherogenesis consequent to COX-2 deletion in mice. |
| Q28222352 | Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal |
| Q51749814 | Effects of parecoxib and dipyrone on platelet aggregation in patients undergoing meniscectomy: a double-blind, randomized, parallel-group study. |
| Q46192896 | Ets-1 mediates platelet-derived growth factor-BB-induced thrombomodulin expression in human vascular smooth muscle cells |
| Q40357741 | Evening primrose oil or forskolin ameliorates celecoxib-enhanced upregulation of tissue factor expression in mice subjected to lipopolysaccharide-induced endotoxemia. |
| Q34827484 | Exogenous Estrogen Does Not Attenuate the Association Between Rofecoxib and Myocardial Infarction in Perimenopausal Women |
| Q36017548 | Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects |
| Q24297941 | JNK-ATF-2 inhibits thrombomodulin (TM) expression by recruiting histone deacetylase4 (HDAC4) and forming a transcriptional repression complex in the TM promoter |
| Q36105461 | Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn |
| Q44897278 | Non-steroidal anti-inflammatory drugs and risk of pulmonary embolism. |
| Q46310741 | Non-steroidal anti-inflammatory drugs and venous thromboembolism in women |
| Q35810610 | Novel insights into the vasoprotective role of heme oxygenase-1 |
| Q36173750 | Selective COX-2 inhibitors and risk of myocardial infarction |
| Q55098865 | Significant common environmental effects on leukocyte subpopulations. |
| Q39399193 | The Cardiovascular Pharmacology of Nonsteroidal Anti-Inflammatory Drugs |
| Q37343216 | The involvement of endothelial mediators in leprosy |
| Q28246124 | Thrombin and vascular inflammation |
| Q25255715 | Upregulated genes in sporadic, idiopathic pulmonary arterial hypertension |
| Q79435229 | [Pain therapy with antipyretic analgesics] |
Search more.